about
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromesHemoglobin E disorder: Newborn screening programTreating iron overload in patients with non-transfusion-dependent thalassemiaOnline biomedical resources for malaria-related red cell disordersBack pain: the sole of presentation of sickle cell disease.Plasma microRNA-451 as a novel hemolytic marker for β0-thalassemia/HbE disease.Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.Liver iron content determination by magnetic resonance imaging.When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.Structural and functional studies indicating altered redox properties of hemoglobin E: implications for production of bioactive nitric oxideFirst Reported Case of Proliferative Retinopathy in Hemoglobin SE DiseaseA transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.Hemoglobin E disease and glycosylated hemoglobin.HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.Newborn screening for hemoglobinopathies in California.Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patientsIron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.Abnormal haemoglobins: detection & characterization.Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia.An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.Thalassaemia in children: from quality of care to quality of life.Hemoglobin disorders in South India.Self-catalytic DNA depurination underlies human β-globin gene mutations at codon 6 that cause anemias and thalassemias.A Rare Case of Hemoglobin E Hemoglobinopathy with Gaucher's Disease.Fatal bone marrow embolism in a child with hemoglobin SE disease.Prevalence of hemoglobin E in Yunnan Province of Southwest China.β-Thalassaemia and its Co-existence with Haemoglobin E and Haemoglobin S in Upper Assam Region of North Eastern India: A Hospital Based StudyHemoglobin E syndromes in Pakistani population.Hemoglobin e syndromes: emerging diagnostic challenge in north India.Unrecognized hemoglobin SE disease as microcytosis.Clinical and hematological features of homozygous hemoglobin O-Arab [beta 121 Glu → Lys].Antioxidant status in haemoglobin E carriers after acute and chronic strenuous exercises.Adrenal insufficiency is prevalent in HbE/β-thalassaemia paediatric patients irrespective of their clinical severity and transfusion requirement.Hydroxyurea for hemoglobin E/β-thalassemia: a systematic review and meta-analysis.Depleted nitric oxide and prostaglandin E2 levels are correlated with endothelial dysfunction in β-thalassemia/HbE patients.A novel test tube method of screening for hemoglobin E.One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
P2860
Q26764818-00D33F9F-4396-45A8-9F00-F5D6D2FBC92AQ26995799-45A8ED0F-9A72-47DA-9DA4-7C30D5732D44Q27009463-38275144-7BD3-4F20-A8F6-36FE4C8B8E3FQ27024694-18C40F74-74F5-41AD-97C1-83C1149853C3Q33610476-597C9680-B355-46C2-B6E4-8AD69C02A53BQ33671658-07ED3916-04E3-4F99-A6A9-F8E245FCE0CEQ33722582-192FE598-8BE5-4D13-A7F0-685F1C66AB4EQ33764777-871440C6-F686-4E1B-BDA7-3395B3A301DAQ34999542-C067611D-BA70-4CB3-9ED9-872D89739E88Q35062875-03298544-8CFF-4883-82D1-C0EB05F94ED3Q35067862-A5A1A4E5-E6CC-402E-9783-50C9ED985A88Q35247241-59A88766-BE68-4C3B-BEF8-3DE554DFD6D6Q35848216-657ABB35-0B3A-447C-B517-56602A1B4348Q36050430-513542C5-5550-40E2-B3E0-721480EB6E27Q36138738-27CCB5D0-A4C7-4E6A-95C8-E7C8C66D3D0BQ36586512-AEE321E8-DB3F-467F-A3CA-02FA9C4C6AA8Q36654528-FFADC7B9-5447-498C-83B9-A18AC540DF1DQ36974108-8DAF5D61-362E-40EB-ABE7-4E0E710FB70AQ37595987-7843E7C7-B93B-465D-B37F-2A4362D5B4B0Q37956961-57FF8A13-E400-4274-81F7-84FF3670F8B3Q38148200-9F9FD268-0A75-489E-B9FB-89FC24051F47Q38423854-E1967206-94E5-427E-9861-D291DA9E95A5Q38435210-5B01CFA1-7946-4B93-8649-D923C221F22FQ38569638-1D66C00C-D0AB-42E3-80AF-1A402BE95561Q38802470-2F846A53-BA63-4422-825D-0F0FBFF8E553Q39959010-E30A8C49-BBE5-45D9-99D5-DFC272F8091EQ40113726-BF7D9D3C-6025-4714-880F-F235514AF8BAQ40367059-88026C9E-EA40-4CF6-A484-D0DEA2330108Q41467048-1D2A478D-BCCF-4BD2-B054-BAFE9BAEF675Q41520183-6CFF4A12-6573-4310-8203-DC06BFDF5E5AQ41981284-3B18D92B-1926-43C8-8160-9C21D036C247Q42241669-22016E01-18C1-4925-A91A-0778368A3E22Q42735677-68E58A75-1D35-4AD6-8342-8FDE5F88C7CEQ44467744-A2EC59C8-FA5B-412F-B896-A7EA20C02102Q44468420-E0619882-9E1E-4557-B3E2-B63050AF9B60Q46331233-E4AA5825-5882-4835-BBE8-E889A1D484B8Q47980084-2CDA8C6B-C1AB-471B-BCED-D48987F7CE56Q48188008-F34BE39A-F5A0-4CDF-B284-7DF78A5AC9F3Q50527006-7B892509-D062-4BA5-90CA-AF19FBA7C176Q52430492-E0507F98-09AA-4A5D-B82B-61F0B26A4405
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Hemoglobin e syndromes.
@ast
Hemoglobin e syndromes.
@en
Hemoglobin e syndromes.
@nl
type
label
Hemoglobin e syndromes.
@ast
Hemoglobin e syndromes.
@en
Hemoglobin e syndromes.
@nl
prefLabel
Hemoglobin e syndromes.
@ast
Hemoglobin e syndromes.
@en
Hemoglobin e syndromes.
@nl
P1476
Hemoglobin e syndromes.
@en
P356
10.1182/ASHEDUCATION-2007.1.79
P577
2007-01-01T00:00:00Z